<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article article-type="research-article" dtd-version="1.3" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="ru"><front><journal-meta><journal-id journal-id-type="publisher-id">mvjr</journal-id><journal-title-group><journal-title xml:lang="ru">Медицинский вестник Юга России</journal-title><trans-title-group xml:lang="en"><trans-title>Medical Herald of the South of Russia</trans-title></trans-title-group></journal-title-group><issn pub-type="ppub">2219-8075</issn><issn pub-type="epub">2618-7876</issn><publisher><publisher-name>The Rostov State Medical University</publisher-name></publisher></journal-meta><article-meta><article-id custom-type="elpub" pub-id-type="custom">mvjr-1218</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="ru"><subject>ОРИГИНАЛЬНЫЕ СТАТЬИ</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="en"><subject>ORIGINAL ARTICLES</subject></subj-group></article-categories><title-group><article-title>Содержание адипокинов в материнской крови при истинной угрозе прерывания беременности</article-title><trans-title-group xml:lang="en"><trans-title>Levels of Adipokines in Blood of Woman with Threatened Abortion</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Шестопалов</surname><given-names>А. В.</given-names></name><name name-style="western" xml:lang="en"><surname>Shestopalov</surname><given-names>A. V.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Кафедра общей и клинической биохимии № 2</p><p>344022, г. Ростов-на-Дону, пер. Нахичеванский, 29</p></bio><bio xml:lang="en"><p>Department of Biochemistry №2</p><p>29 Nakhichevansky st., Rostov-on-Don, 344022</p></bio><email xlink:type="simple">contrarius@yandex.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Шульга</surname><given-names>А. С.</given-names></name><name name-style="western" xml:lang="en"><surname>Shul’ga</surname><given-names>A. S.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Кафедра общей и клинической биохимии № 2</p><p>344022, г. Ростов-на-Дону, пер. Нахичеванский, 29</p></bio><bio xml:lang="en"><p>Department of Biochemistry №2</p><p>29 Nakhichevansky st., Rostov-on-Don, 344022</p></bio><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Рымашевский</surname><given-names>А. Н.</given-names></name><name name-style="western" xml:lang="en"><surname>Rymashevskij</surname><given-names>A. N.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Кафедра акушерства и гинекологии № 1</p><p>344022, г. Ростов-на-Дону, пер. Нахичеванский, 29</p></bio><bio xml:lang="en"><p>Department of Obstetrics and Gynecology №1 29 Nakhichevansky st., Rostov-on-Don, 344022</p></bio><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Ставиский</surname><given-names>И. М.</given-names></name><name name-style="western" xml:lang="en"><surname>Staviskij</surname><given-names>I. M.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Кафедра общей и клинической биохимии № 2</p><p>344022, г. Ростов-на-Дону, пер. Нахичеванский, 29</p></bio><bio xml:lang="en"><p>Department of Biochemistry №2</p><p>29 Nakhichevansky st., Rostov-on-Don, 344022</p></bio><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Александрова</surname><given-names>А. А.</given-names></name><name name-style="western" xml:lang="en"><surname>Aleksandrova</surname><given-names>A. A.</given-names></name></name-alternatives><bio xml:lang="ru"><p>344104, г. Ростов-на-Дону, пр. Стачки 194/1</p></bio><bio xml:lang="en"><p>194/1 Stachki str., Rostov-on-Don, 344104</p></bio><xref ref-type="aff" rid="aff-2"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Шкурат</surname><given-names>Т. П.</given-names></name><name name-style="western" xml:lang="en"><surname>Shkurat</surname><given-names>T. P.</given-names></name></name-alternatives><bio xml:lang="ru"/><bio xml:lang="en"><p>194/1 Stachki str., Rostov-on-Don, 344104</p></bio><xref ref-type="aff" rid="aff-2"/></contrib></contrib-group><aff-alternatives id="aff-1"><aff xml:lang="ru"><institution>Ростовский государственный медицинский университет</institution><country>Россия</country></aff><aff xml:lang="en"><institution>Rostov State Medical University</institution><country>Russian Federation</country></aff></aff-alternatives><aff-alternatives id="aff-2"><aff xml:lang="ru"><institution>Южный федеральный университет, НИИ биологии</institution><country>Россия</country></aff><aff xml:lang="en"><institution>Southern Federal University, Research institute for biology</institution><country>Russian Federation</country></aff></aff-alternatives><pub-date pub-type="collection"><year>2012</year></pub-date><pub-date pub-type="epub"><day>30</day><month>09</month><year>2012</year></pub-date><volume>0</volume><issue>3</issue><fpage>52</fpage><lpage>55</lpage><permissions><copyright-statement>Copyright &amp;#x00A9; Шестопалов А.В., Шульга А.С., Рымашевский А.Н., Ставиский И.М., Александрова А.А., Шкурат Т.П., 2012</copyright-statement><copyright-year>2012</copyright-year><copyright-holder xml:lang="ru">Шестопалов А.В., Шульга А.С., Рымашевский А.Н., Ставиский И.М., Александрова А.А., Шкурат Т.П.</copyright-holder><copyright-holder xml:lang="en">Shestopalov A.V., Shul’ga A.S., Rymashevskij A.N., Staviskij I.M., Aleksandrova A.A., Shkurat T.P.</copyright-holder><license xml:lang="ru" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>Данная работа распространяется под лицензией Creative Commons Attribution 4.0.</license-p></license><license xml:lang="en" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>This work is licensed under a Creative Commons Attribution 4.0 License.</license-p></license></permissions><self-uri xlink:href="https://www.medicalherald.ru/jour/article/view/1218">https://www.medicalherald.ru/jour/article/view/1218</self-uri><abstract><p>Цель: определение уровней адипокинов и показателей углеводного обмена в крови женщин с истинной угрозой прерывания беременности (истмико-цервикальная недостаточность). Материалы и методы: в исследовании участвовали женщины в сроке 16 – 26 нед. гестации – 18 женщин с истинной угрозой прерывания беременности и 52 женщины с физиологическим течением беременности. Оценивались уровни адипонектина, лептина, резистина, глюкозы, инсулина и значение индекса инсулинорезистентности HOMA-IR. Результаты: в крови женщин с истинной угрозой прерывания беременности выявляются существенные изменения в углеводном обмене в виде нарастания уровней инсулина и глюкозы, а также увеличения значения индекса инсулинорезистентности (р&lt;0,001). Достоверных различий между исследуемыми группами по возрасту и индексу массы тела не определяется. В группе женщин с истинной угрозой прерывания беременности статистически значимо возрастает уровень лептина (р=0,04), а также наблюдается уменьшение концентрации резистина (р=0,02). Уровень адипонектина статистически значимо не изменяется. Заключение: при истинной угрозе прерывания беременности увеличивается уровень лептина и снижается концентрация резистина, а также определяется развитие патологической инсулинорезистентности.</p></abstract><trans-abstract xml:lang="en"><sec><title>Purpose</title><p>Purpose: To investigate levels of adipokines and indicators of carbohydrate metabolism in the blood of women with a true threat of pregnancy termination (isthmico-cervical insufficiency). Materials and Methods: The study involved women in the period of 16 – 26 weeks of gestation – 18 women with a true threat of termination of pregnancy and 52 women with physiological pregnancy. Both groups were compared with levels of leptin, resistin, adiponectin, fasting glucose, fasting insulin and homeostasis model assessment of insulin resistance (HOMA-IR). Results: In the blood of women with a real threat of pregnancy termination are revealed significant changes in carbohydrate metabolism – the increase in levels of fasting insulin and glucose, and also increase the value of the index of insulin resistance HOMA-IR (p&lt;0.001). No significant differences in age and BMI index were found between the study and control subjects. In the group of women with the true threat of pregnancy termination significantly increases the level of leptin (p=0.04), and there is also a decrease in the concentration of resistin (p=0.02). The level of adiponectin significant does not change.</p></sec><sec><title>Summary</title><p>Summary: Compared with the control group, patients with RPL were more likely to have insulin resistance. In condition of the true threat of pregnancy termination increases the level of leptin and reduced the concentration of resistin, and is determined the development of pathological insulin resistance.</p></sec></trans-abstract><kwd-group xml:lang="ru"><kwd>истинная угроза прерывания беременности</kwd><kwd>лептин</kwd><kwd>адипонектин</kwd><kwd>резистин</kwd><kwd>инсулин</kwd><kwd>глюкоза</kwd><kwd>HOMA-IR</kwd></kwd-group><kwd-group xml:lang="en"><kwd>threatened abortion</kwd><kwd>leptin</kwd><kwd>adiponectin</kwd><kwd>resistin</kwd><kwd>insulin</kwd><kwd>glucose</kwd><kwd>HOMA-IR</kwd></kwd-group><funding-group><funding-statement xml:lang="ru">Исследования выполнены в рамках госконтракта № 02.740.11.05.01. ФЦП «Научные и научно-педагогические кадры инновационной России на 2009-2013 гг» и тематического плана НИИ биологии ЮФУ на 2010-2011 годы.</funding-statement></funding-group></article-meta></front><back><ref-list><title>References</title><ref id="cit1"><label>1</label><citation-alternatives><mixed-citation xml:lang="ru">Cervical ripening and insufficiency: from biochemical and molecular studies to in vivo clinical examination / D. Schlembach [et al.] // Eur. J. Obstet. Gynecol. Reprod. Biol. – 2009. – Vol. 144, № 1. – P. 70 – 76.</mixed-citation><mixed-citation xml:lang="en">Cervical ripening and insufficiency: from biochemical and molecular studies to in vivo clinical examination / D. Schlembach [et al.] // Eur. J. Obstet. Gynecol. Reprod. Biol. – 2009. – Vol. 144, № 1. – P. 70 – 76.</mixed-citation></citation-alternatives></ref><ref id="cit2"><label>2</label><citation-alternatives><mixed-citation xml:lang="ru">Суханова, Л.П. Родовспоможение в России – состояние, тенденции развития, пути совершенствования / Л.П. Суханова, С.А. Леонов // Социальные аспекты здоровья населения. – 2010. – № 2. – С. 15 – 17.</mixed-citation><mixed-citation xml:lang="en">Суханова, Л.П. Родовспоможение в России – состояние, тенденции развития, пути совершенствования / Л.П. Суханова, С.А. Леонов // Социальные аспекты здоровья населения. – 2010. – № 2. – С. 15 – 17.</mixed-citation></citation-alternatives></ref><ref id="cit3"><label>3</label><citation-alternatives><mixed-citation xml:lang="ru">Adipokines: New Emerging Roles in Fertility and Reproduction / C. Tersigni [et al.] // Obstetrical &amp; Gynecological Survey. – 2011. – Vol. 66. – № 1 – P. 47-63.</mixed-citation><mixed-citation xml:lang="en">Adipokines: New Emerging Roles in Fertility and Reproduction / C. Tersigni [et al.] // Obstetrical &amp; Gynecological Survey. – 2011. – Vol. 66. – № 1 – P. 47-63.</mixed-citation></citation-alternatives></ref><ref id="cit4"><label>4</label><citation-alternatives><mixed-citation xml:lang="ru">Unger, R. H. Diseases of liporegulation: new perspective on obesity and related disorders / R. H. Unger, L. Orci // FASEB J. – 2001. – 15. – P. 312–321.</mixed-citation><mixed-citation xml:lang="en">Unger, R. H. Diseases of liporegulation: new perspective on obesity and related disorders / R. H. Unger, L. Orci // FASEB J. – 2001. – 15. – P. 312–321.</mixed-citation></citation-alternatives></ref><ref id="cit5"><label>5</label><citation-alternatives><mixed-citation xml:lang="ru">Patrick, M. Obesity, insulin resistance, and pregnancy outcome / M. Patrick, В. Catalano // Reproduction. – 2010. – № 140. – P. 365- 371.</mixed-citation><mixed-citation xml:lang="en">Patrick, M. Obesity, insulin resistance, and pregnancy outcome / M. Patrick, В. Catalano // Reproduction. – 2010. – № 140. – P. 365- 371.</mixed-citation></citation-alternatives></ref><ref id="cit6"><label>6</label><citation-alternatives><mixed-citation xml:lang="ru">Craig, L. B. Increased prevalence of insulin resistance in women with a history of recurrent pregnancy loss / L. B. Craig, R. W. Ke, W. H. Kutteh // Fertil. Steril. – 2002. – № 78. – P. 487–490.</mixed-citation><mixed-citation xml:lang="en">Craig, L. B. Increased prevalence of insulin resistance in women with a history of recurrent pregnancy loss / L. B. Craig, R. W. Ke, W. H. Kutteh // Fertil. Steril. – 2002. – № 78. – P. 487–490.</mixed-citation></citation-alternatives></ref><ref id="cit7"><label>7</label><citation-alternatives><mixed-citation xml:lang="ru">Evaluation of the relationship between insulin resistance and recurrent pregnancy loss / N. Celik [et al.] // Ginekol. Pol. – 2011. – Vol. 82, № 4 – P. 272-275.</mixed-citation><mixed-citation xml:lang="en">Evaluation of the relationship between insulin resistance and recurrent pregnancy loss / N. Celik [et al.] // Ginekol. Pol. – 2011. – Vol. 82, № 4 – P. 272-275.</mixed-citation></citation-alternatives></ref><ref id="cit8"><label>8</label><citation-alternatives><mixed-citation xml:lang="ru">Anti-diabetic drugs inhibit obesity-linked phosphorylation of PPARgamma by Cdk5 / J. H. Choi [et al.] // Nature. – 2010. – Vol. 22, № 6. – P. 451-456.</mixed-citation><mixed-citation xml:lang="en">Anti-diabetic drugs inhibit obesity-linked phosphorylation of PPARgamma by Cdk5 / J. H. Choi [et al.] // Nature. – 2010. – Vol. 22, № 6. – P. 451-456.</mixed-citation></citation-alternatives></ref><ref id="cit9"><label>9</label><citation-alternatives><mixed-citation xml:lang="ru">Angiotensin-(1-7) prevents diabetes-induced attenuation in PPARgamma and catalase activities / G. S. Dhaunsi [et al.] // Eur. J. Pharmacol. – 2010. – Vol. 63, №3. – P. 108 – 114.</mixed-citation><mixed-citation xml:lang="en">Angiotensin-(1-7) prevents diabetes-induced attenuation in PPARgamma and catalase activities / G. S. Dhaunsi [et al.] // Eur. J. Pharmacol. – 2010. – Vol. 63, №3. – P. 108 – 114.</mixed-citation></citation-alternatives></ref><ref id="cit10"><label>10</label><citation-alternatives><mixed-citation xml:lang="ru">Rosen, E.D. PPARγ : a nuclear regulator of metabolism, differentiation, and cell growth / E. D. Rosen, B. M. Spiegelman // J. Biol. Chem. – 2001. – № 276. – P. 37731 – 37734.</mixed-citation><mixed-citation xml:lang="en">Rosen, E.D. PPARγ : a nuclear regulator of metabolism, differentiation, and cell growth / E. D. Rosen, B. M. Spiegelman // J. Biol. Chem. – 2001. – № 276. – P. 37731 – 37734.</mixed-citation></citation-alternatives></ref><ref id="cit11"><label>11</label><citation-alternatives><mixed-citation xml:lang="ru">The effect of pioglitazone on peroxisome proliferator-activated receptor-gamma target genes related to lipid storage in vivo / I. Bogacka [et al.] // Diabetes Care. – 2004. – Vol. 27, №7. – P. 1660-1667.</mixed-citation><mixed-citation xml:lang="en">The effect of pioglitazone on peroxisome proliferator-activated receptor-gamma target genes related to lipid storage in vivo / I. Bogacka [et al.] // Diabetes Care. – 2004. – Vol. 27, №7. – P. 1660-1667.</mixed-citation></citation-alternatives></ref><ref id="cit12"><label>12</label><citation-alternatives><mixed-citation xml:lang="ru">PPAR-alpha-null mice are protected from high-fat diet-induced insulin resistance / M. Guerre-Millo [et al.] // Diabetes. – 2001. – Vol. 50, № 12. – P. 2809-2814.</mixed-citation><mixed-citation xml:lang="en">PPAR-alpha-null mice are protected from high-fat diet-induced insulin resistance / M. Guerre-Millo [et al.] // Diabetes. – 2001. – Vol. 50, № 12. – P. 2809-2814.</mixed-citation></citation-alternatives></ref><ref id="cit13"><label>13</label><citation-alternatives><mixed-citation xml:lang="ru">Waist circumference, ghrelin and selected adipose tissue-derived adipokines as predictors of insulin resistance in obese patients: preliminary results / M. Stepien [et al.] // Med. Sci. Monit. – 2011. – Vol. 17, № 11. – P. 13-18.</mixed-citation><mixed-citation xml:lang="en">Waist circumference, ghrelin and selected adipose tissue-derived adipokines as predictors of insulin resistance in obese patients: preliminary results / M. Stepien [et al.] // Med. Sci. Monit. – 2011. – Vol. 17, № 11. – P. 13-18.</mixed-citation></citation-alternatives></ref><ref id="cit14"><label>14</label><citation-alternatives><mixed-citation xml:lang="ru">Leptin produced by joint white adipose tissue induces cartilage degradation via upregulation and activation of matrix metalloproteinases / Hui W. [et al.] // Ann. Rheum. Dis. – 2011. – Vol. 27, № 12. – P. 13-18.</mixed-citation><mixed-citation xml:lang="en">Leptin produced by joint white adipose tissue induces cartilage degradation via upregulation and activation of matrix metalloproteinases / Hui W. [et al.] // Ann. Rheum. Dis. – 2011. – Vol. 27, № 12. – P. 13-18.</mixed-citation></citation-alternatives></ref><ref id="cit15"><label>15</label><citation-alternatives><mixed-citation xml:lang="ru">Matrix metalloproteinase-9 is increased in obese subjects and decreases in response to pioglitazone / R. Unal [et al.] // J. Clin. Endocrinol. Metab. – 2010. – Vol. 95, №6. – P. 2993 – 3001.</mixed-citation><mixed-citation xml:lang="en">Matrix metalloproteinase-9 is increased in obese subjects and decreases in response to pioglitazone / R. Unal [et al.] // J. Clin. Endocrinol. Metab. – 2010. – Vol. 95, №6. – P. 2993 – 3001.</mixed-citation></citation-alternatives></ref><ref id="cit16"><label>16</label><citation-alternatives><mixed-citation xml:lang="ru">Insulin regulates leptin secretion from 3T3–L1 adipocytes by a PI 3 kinase independent mechanism / A. Zeigerera [et al.] // Experimental Cell Research – 2008. – Vol. 314. – № 11 – P. 2249-2256.</mixed-citation><mixed-citation xml:lang="en">Insulin regulates leptin secretion from 3T3–L1 adipocytes by a PI 3 kinase independent mechanism / A. Zeigerera [et al.] // Experimental Cell Research – 2008. – Vol. 314. – № 11 – P. 2249-2256.</mixed-citation></citation-alternatives></ref><ref id="cit17"><label>17</label><citation-alternatives><mixed-citation xml:lang="ru">Resistin induces insulin resistance by both AMPK-dependent and AMPK-independent mechanisms in HepG2 cells / Z. Luo [et al.] // Endocrine. – 2009. – Vol. 36, № 1. – P. 60-69.с.</mixed-citation><mixed-citation xml:lang="en">Resistin induces insulin resistance by both AMPK-dependent and AMPK-independent mechanisms in HepG2 cells / Z. Luo [et al.] // Endocrine. – 2009. – Vol. 36, № 1. – P. 60-69.с.</mixed-citation></citation-alternatives></ref></ref-list><fn-group><fn fn-type="conflict"><p>The authors declare that there are no conflicts of interest present.</p></fn></fn-group></back></article>
